Peginterferon alfa-2b (SCH 54031)

BIOLOGICAL11 trials

Sponsors

Merck Sharp & Dohme LLC, Schering-Plough

Conditions

Chronic Hepatitis CCirrhosisHepacivirusHepatitis C, ChronicLiver Fibrosis

Phase 3

Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)

CompletedNCT00048724

Merck Sharp & Dohme LLCChronic Hepatitis C, Cirrhosis

Start: 2002-06-30End: 2008-04-30Updated: 2017-04-04

Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)

CompletedNCT00049842

Merck Sharp & Dohme LLCChronic Hepatitis C, Liver Fibrosis

Start: 2002-10-31End: 2009-10-31Updated: 2017-04-04

Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)

CompletedNCT00302081

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2003-08-31End: 2008-04-30Updated: 2017-04-05

Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514)

CompletedNCT00910624

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2009-06-22End: 2012-12-07Updated: 2021-02-08

Unknown Phase

Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)

CompletedNCT00704522

Merck Sharp & Dohme LLCHepacivirus, Hepatitis C, Chronic

Start: 2005-03-31End: 2009-04-30Updated: 2015-10-06

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)

CompletedNCT00705666

Merck Sharp & Dohme LLCHepacivirus, Hepatitis C, Chronic

Start: 2006-02-28End: 2008-07-31Updated: 2015-10-02

Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)

CompletedNCT00705263

Schering-PloughHepacivirus, Hepatitis C, Chronic

Start: 2005-10-31End: 2008-05-31Updated: 2009-08-25

PegIntron Injection Surveillance Plan (Study P04123)

CompletedNCT00723931

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2006-06-30End: 2009-11-30Updated: 2015-11-04

Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)

TerminatedNCT00723879

Merck Sharp & Dohme LLCHepacivirus, Hepatitis C, Chronic

Start: 2004-10-31End: 2008-07-31Updated: 2015-11-03

Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)

CompletedNCT00724373

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2007-11-30End: 2009-02-28Updated: 2015-09-25

Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)

CompletedNCT00727259

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2004-10-31End: 2008-04-30Updated: 2015-04-29